Nuclear PI-PLC β1 and myelodysplastic syndromes: From bench to clinics

Sara Mongiorgi, Matilde Y. Follo, Cristina Clissa, Roberto Giardino, Milena Fini, Lucia Manzoli, Giulia Ramazzotti, Roberta Fiume, Carlo Finelli, Lucio Cocco

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Myelodysplastic syndromes (MDS), clonal hematopoietic stem-cell disorders mainly affecting older adult patients, show ineffective hematopoiesis in one or more of the lineages of the bone marrow. A number of MDS progresses to acute myeloid leukemia (AML) with the involvement of genetic and epigenetic mechanisms affecting PI-PLC β1. The molecular mechanisms underlying the MDS evolution to AML are still unclear, even though it is now clear that the nuclear signaling elicited by PI-PLC β1, Cyclin D3, and Akt plays an important role in the control of the balance between cell cycle progression and apoptosis in both normal and pathologic conditions. Moreover, a correlation between other PI-PLCs, such as PI-PLC β3, kinases and phosphatases has been postulated in MDS pathogenesis. Here, we review the findings hinting at the role of nuclear lipid signaling pathways in MDS, which could become promising therapeutic targets.

Original languageEnglish
Title of host publicationCurrent Topics in Microbiology and Immunology
Pages235-245
Number of pages11
Volume362
DOIs
Publication statusPublished - 2012

Publication series

NameCurrent Topics in Microbiology and Immunology
Volume362
ISSN (Print)0070217X

Fingerprint

Myelodysplastic Syndromes
Acute Myeloid Leukemia
Cyclin D3
Hematopoiesis
Hematopoietic Stem Cells
Phosphatidylinositol 3-Kinases
Phosphoric Monoester Hydrolases
Epigenomics
Cell Cycle
Bone Marrow
Apoptosis
Lipids

ASJC Scopus subject areas

  • Immunology and Allergy
  • Microbiology (medical)
  • Immunology
  • Microbiology

Cite this

Mongiorgi, S., Follo, M. Y., Clissa, C., Giardino, R., Fini, M., Manzoli, L., ... Cocco, L. (2012). Nuclear PI-PLC β1 and myelodysplastic syndromes: From bench to clinics. In Current Topics in Microbiology and Immunology (Vol. 362, pp. 235-245). (Current Topics in Microbiology and Immunology; Vol. 362). https://doi.org/10.1007/978-94-007-5025-8-11

Nuclear PI-PLC β1 and myelodysplastic syndromes : From bench to clinics. / Mongiorgi, Sara; Follo, Matilde Y.; Clissa, Cristina; Giardino, Roberto; Fini, Milena; Manzoli, Lucia; Ramazzotti, Giulia; Fiume, Roberta; Finelli, Carlo; Cocco, Lucio.

Current Topics in Microbiology and Immunology. Vol. 362 2012. p. 235-245 (Current Topics in Microbiology and Immunology; Vol. 362).

Research output: Chapter in Book/Report/Conference proceedingChapter

Mongiorgi, S, Follo, MY, Clissa, C, Giardino, R, Fini, M, Manzoli, L, Ramazzotti, G, Fiume, R, Finelli, C & Cocco, L 2012, Nuclear PI-PLC β1 and myelodysplastic syndromes: From bench to clinics. in Current Topics in Microbiology and Immunology. vol. 362, Current Topics in Microbiology and Immunology, vol. 362, pp. 235-245. https://doi.org/10.1007/978-94-007-5025-8-11
Mongiorgi S, Follo MY, Clissa C, Giardino R, Fini M, Manzoli L et al. Nuclear PI-PLC β1 and myelodysplastic syndromes: From bench to clinics. In Current Topics in Microbiology and Immunology. Vol. 362. 2012. p. 235-245. (Current Topics in Microbiology and Immunology). https://doi.org/10.1007/978-94-007-5025-8-11
Mongiorgi, Sara ; Follo, Matilde Y. ; Clissa, Cristina ; Giardino, Roberto ; Fini, Milena ; Manzoli, Lucia ; Ramazzotti, Giulia ; Fiume, Roberta ; Finelli, Carlo ; Cocco, Lucio. / Nuclear PI-PLC β1 and myelodysplastic syndromes : From bench to clinics. Current Topics in Microbiology and Immunology. Vol. 362 2012. pp. 235-245 (Current Topics in Microbiology and Immunology).
@inbook{1bdf44c157544ba8b40239b956817853,
title = "Nuclear PI-PLC β1 and myelodysplastic syndromes: From bench to clinics",
abstract = "Myelodysplastic syndromes (MDS), clonal hematopoietic stem-cell disorders mainly affecting older adult patients, show ineffective hematopoiesis in one or more of the lineages of the bone marrow. A number of MDS progresses to acute myeloid leukemia (AML) with the involvement of genetic and epigenetic mechanisms affecting PI-PLC β1. The molecular mechanisms underlying the MDS evolution to AML are still unclear, even though it is now clear that the nuclear signaling elicited by PI-PLC β1, Cyclin D3, and Akt plays an important role in the control of the balance between cell cycle progression and apoptosis in both normal and pathologic conditions. Moreover, a correlation between other PI-PLCs, such as PI-PLC β3, kinases and phosphatases has been postulated in MDS pathogenesis. Here, we review the findings hinting at the role of nuclear lipid signaling pathways in MDS, which could become promising therapeutic targets.",
author = "Sara Mongiorgi and Follo, {Matilde Y.} and Cristina Clissa and Roberto Giardino and Milena Fini and Lucia Manzoli and Giulia Ramazzotti and Roberta Fiume and Carlo Finelli and Lucio Cocco",
year = "2012",
doi = "10.1007/978-94-007-5025-8-11",
language = "English",
isbn = "9789400750241",
volume = "362",
series = "Current Topics in Microbiology and Immunology",
pages = "235--245",
booktitle = "Current Topics in Microbiology and Immunology",

}

TY - CHAP

T1 - Nuclear PI-PLC β1 and myelodysplastic syndromes

T2 - From bench to clinics

AU - Mongiorgi, Sara

AU - Follo, Matilde Y.

AU - Clissa, Cristina

AU - Giardino, Roberto

AU - Fini, Milena

AU - Manzoli, Lucia

AU - Ramazzotti, Giulia

AU - Fiume, Roberta

AU - Finelli, Carlo

AU - Cocco, Lucio

PY - 2012

Y1 - 2012

N2 - Myelodysplastic syndromes (MDS), clonal hematopoietic stem-cell disorders mainly affecting older adult patients, show ineffective hematopoiesis in one or more of the lineages of the bone marrow. A number of MDS progresses to acute myeloid leukemia (AML) with the involvement of genetic and epigenetic mechanisms affecting PI-PLC β1. The molecular mechanisms underlying the MDS evolution to AML are still unclear, even though it is now clear that the nuclear signaling elicited by PI-PLC β1, Cyclin D3, and Akt plays an important role in the control of the balance between cell cycle progression and apoptosis in both normal and pathologic conditions. Moreover, a correlation between other PI-PLCs, such as PI-PLC β3, kinases and phosphatases has been postulated in MDS pathogenesis. Here, we review the findings hinting at the role of nuclear lipid signaling pathways in MDS, which could become promising therapeutic targets.

AB - Myelodysplastic syndromes (MDS), clonal hematopoietic stem-cell disorders mainly affecting older adult patients, show ineffective hematopoiesis in one or more of the lineages of the bone marrow. A number of MDS progresses to acute myeloid leukemia (AML) with the involvement of genetic and epigenetic mechanisms affecting PI-PLC β1. The molecular mechanisms underlying the MDS evolution to AML are still unclear, even though it is now clear that the nuclear signaling elicited by PI-PLC β1, Cyclin D3, and Akt plays an important role in the control of the balance between cell cycle progression and apoptosis in both normal and pathologic conditions. Moreover, a correlation between other PI-PLCs, such as PI-PLC β3, kinases and phosphatases has been postulated in MDS pathogenesis. Here, we review the findings hinting at the role of nuclear lipid signaling pathways in MDS, which could become promising therapeutic targets.

UR - http://www.scopus.com/inward/record.url?scp=84870031043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870031043&partnerID=8YFLogxK

U2 - 10.1007/978-94-007-5025-8-11

DO - 10.1007/978-94-007-5025-8-11

M3 - Chapter

C2 - 23086421

AN - SCOPUS:84870031043

SN - 9789400750241

VL - 362

T3 - Current Topics in Microbiology and Immunology

SP - 235

EP - 245

BT - Current Topics in Microbiology and Immunology

ER -